BPC-157 + TB-500
20mg
BPC-157 + TB-500 20 mg is a combined formulation of two research peptides: BPC-157, a synthetic 15-amino-acid pentadecapeptide, and TB-500, a synthetic analogue of thymosin β-4. The combination is studied in preclinical research for effects on angiogenesis, extracellular-matrix dynamics, and inflammatory signalling. Supplied for laboratory research use only; not for human or animal consumption.
Lyophilized powder · Requires reconstitution prior to research use.
Sold for research purposes only
$80.00
Research use only. Not for human or animal consumption. Terms
In stock
Not for human or animal consumption.
Documentation
BPC-157 + TB-500 20 mg is an investigational peptide formulation combining BPC-157 with TB-500. BPC-157 is a synthetic 15-amino-acid pentadecapeptide reported in preclinical literature to promote angiogenesis, modulate nitric oxide synthase activity and growth-factor signalling, and influence extracellular-matrix protein production and remodelling. TB-500 is a synthetic analogue of thymosin β-4, a polypeptide studied for its role in cytoskeletal dynamics; it regulates actin polymerisation, facilitates cell migration, and up-regulates endothelial proliferation and capillary formation, contributing to angiogenesis in research models.
Related research peptides
